Amphastar Pharmaceuticals Announces Board and Compensation Changes
Ticker: AMPH · Form: 8-K · Filed: Jul 21, 2025 · CIK: 1297184
| Field | Detail |
|---|---|
| Company | Amphastar Pharmaceuticals, Inc. (AMPH) |
| Form Type | 8-K |
| Filed Date | Jul 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: AMPH
TL;DR
Amphastar's board shuffled, exec pay tweaked. Watch for new strategy.
AI Summary
Amphastar Pharmaceuticals, Inc. announced on July 18, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure of a director and the election of a new director, along with updates to certain officers' compensatory arrangements.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing details routine corporate governance changes and compensation adjustments, which typically carry low immediate risk.
Key Players & Entities
- Amphastar Pharmaceuticals, Inc. (company) — Registrant
- July 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Rancho Cucamonga, California (location) — Principal executive offices
FAQ
Who departed from the board of directors?
The filing indicates the departure of a director, but the specific name is not provided in the provided text.
Who was elected to the board of directors?
The filing states that a new director was elected, but their name is not specified in the provided text.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is July 18, 2025.
What is the principal executive office address of Amphastar Pharmaceuticals, Inc.?
The principal executive offices are located at 11570 6th Street, Rancho Cucamonga, California 91730.
What specific compensatory arrangements were updated?
The filing mentions updates to the compensatory arrangements of certain officers, but the details of these arrangements are not specified in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 21, 2025 regarding Amphastar Pharmaceuticals, Inc. (AMPH).